These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 1383955

  • 1. The effects of type I antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ, Kidwell GA, DeCaro M, Hessen S.
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1445-53. PubMed ID: 1383955
    [Abstract] [Full Text] [Related]

  • 2. Prediction of antiarrhythmic efficacy of class I and III agents in patients with ventricular tachycardia by signal-averaged ECG analysis.
    Kulakowski P, Bashir Y, Heald S, Paul V, Anderson MH, Gibson S, Malik M, Camm AJ.
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2116-21. PubMed ID: 1279610
    [Abstract] [Full Text] [Related]

  • 3. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.
    Brembilla-Perrot B, Claudon O, Houriez P, Beurrier D, Suty-Selton C.
    Int J Cardiol; 2002 Apr; 83(1):47-55. PubMed ID: 11959384
    [Abstract] [Full Text] [Related]

  • 4. The signal-averaged electrocardiogram is of limited value in patients with bundle branch block and dilated cardiomyopathy in predicting inducible ventricular tachycardia or death.
    Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, Beurrier D, Houplon P.
    Am J Cardiol; 1997 Jan 15; 79(2):154-9. PubMed ID: 9193015
    [Abstract] [Full Text] [Related]

  • 5. Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: relation to slowing of ventricular tachycardia. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial (ESVEM) Investigators.
    Freedman RA, Steinberg JS.
    J Am Coll Cardiol; 1991 Apr 15; 17(5):1017-25. PubMed ID: 1848871
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive prediction of efficacy of type IA antiarrhythmic drugs by the signal-averaged electrocardiogram in patients with coronary artery disease and sustained ventricular tachycardia.
    Hopson JR, Kienzle MG, Aschoff AM, Shirkey DR.
    Am J Cardiol; 1993 Aug 01; 72(3):288-93. PubMed ID: 8342506
    [Abstract] [Full Text] [Related]

  • 7. Time domain analysis of the signal averaged electrocardiogram in patients with a conduction defect or a bundle branch block.
    Gatzoulis KA, Carlson MD, Biblo LA, Rizos I, Gialafos J, Toutouzas P, Waldo AL.
    Eur Heart J; 1995 Dec 01; 16(12):1912-9. PubMed ID: 8682026
    [Abstract] [Full Text] [Related]

  • 8. Effects of procainamide on the signal-averaged electrocardiogram in relation to the results of programmed ventricular stimulation in patients with sustained monomorphic ventricular tachycardia.
    Kulakowski P, Bashir Y, Heald S, Paul V, Anderson MH, Gibson S, Malik M, Camm AJ.
    J Am Coll Cardiol; 1993 May 01; 21(6):1428-39. PubMed ID: 8473652
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiologic effects and predictors of success of combination therapy with class Ia and Ib antiarrhythmic drugs for sustained ventricular arrhythmias.
    Foster MT, Peters RW, Froman D, Shorofsky SR, Gold MR.
    Am J Cardiol; 1996 Jul 01; 78(1):47-50. PubMed ID: 8712117
    [Abstract] [Full Text] [Related]

  • 10. The effects of antiarrhythmic drugs on the signal-averaged electrocardiogram in patients with malignant ventricular arrhythmias.
    Greenspon AJ, Kidwell GA.
    Prog Cardiovasc Dis; 1993 Jul 01; 35(6):399-406. PubMed ID: 8497655
    [Abstract] [Full Text] [Related]

  • 11. Effects of sotalol on the signal-averaged electrocardiogram in patients with sustained ventricular tachycardia: relation to suppression of inducibility and changes in tachycardia cycle length.
    Freedman RA, Karagounis LA, Steinberg JS.
    J Am Coll Cardiol; 1992 Nov 01; 20(5):1213-9. PubMed ID: 1401624
    [Abstract] [Full Text] [Related]

  • 12. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram.
    Anderson KP, Bigger JT, Freedman RA.
    Prog Cardiovasc Dis; 1996 Nov 01; 38(6):463-88. PubMed ID: 8638028
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy.
    Mancini DM, Wong KL, Simson MB.
    Circulation; 1993 Apr 01; 87(4):1083-92. PubMed ID: 8462136
    [Abstract] [Full Text] [Related]

  • 14. The effects of class I drugs on the cycle length of sustained ventricular tachycardia and the signal-averaged electrocardiogram.
    Doi T, Inoue T, Ohnishi Y, Yokoyama M.
    Jpn Circ J; 1997 Jun 01; 61(6):495-502. PubMed ID: 9225195
    [Abstract] [Full Text] [Related]

  • 15. Study of the influence of left bundle branch block on the signal-averaged electrocardiogram: a qualitative and quantitative analysis.
    Fontaine JM, Rao R, Henkin R, Suneja R, Ursell SN, el-Sherif N.
    Am Heart J; 1991 Feb 01; 121(2 Pt 1):494-508. PubMed ID: 1990754
    [Abstract] [Full Text] [Related]

  • 16. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ, Mitchell LB, Gillis AM, Sheldon RS, Chudleigh L, Cassidy P, Chiamvimonvat N, Wyse DG.
    Circulation; 1993 Sep 01; 88(3):1054-62. PubMed ID: 8353867
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
    Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN.
    Circulation; 1993 Mar 01; 87(3):783-92. PubMed ID: 8443899
    [Abstract] [Full Text] [Related]

  • 18. The effects of atrial pacing on the signal-averaged electrocardiogram in patients with coronary artery disease.
    Greenspon AJ, Volosin K.
    Am Heart J; 1990 Jan 01; 119(1):29-34. PubMed ID: 2296870
    [Abstract] [Full Text] [Related]

  • 19. Behavior of late potentials on the body surface during programmed ventricular stimulation.
    Ho DS, Daly M, Richards DA, Uther JB, Ross DL.
    J Am Coll Cardiol; 1996 Nov 01; 28(5):1283-91. PubMed ID: 8890828
    [Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT, Nademanee K, Antimisiaris M, Pacifico A, Pruitt C, Godfrey R, Singh BN.
    Circulation; 1993 Sep 01; 88(3):1072-82. PubMed ID: 8353869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.